van Doorn L J, Schneeberger P M, Nouhan N, Plaisier A P, Quint W G, de Boer W A
Delft Diagnostic Laboratory, Delft, The Netherlands.
Gut. 2000 Mar;46(3):321-6. doi: 10.1136/gut.46.3.321.
Virulence factors of Helicobacter pylori are associated with peptic ulcer disease and may be also associated with the efficacy of treatment.
To determine the relation between the vacA and the cagA status of H pylori, clinical disease, and treatment outcome.
121 patients with H pylori infection and peptic ulcer disease or functional dyspepsia were treated by quadruple antibiotic therapy in two groups for one and two days, respectively.
DNA was isolated from gastric antral biopsy specimens, taken before and after treatment, and the vacA and cagA status was determined by polymerase chain reaction and reverse hybridisation.
Peptic ulcer disease was significantly associated with the vacA s1 type, and cagA positivity, but not with the vacA m type. Treatment efficacy was significantly higher in patients with peptic ulcer disease, or infected with cagA+/vacA s1 strains.
The strong association between the cagA and vacA status and peptic ulcer disease was confirmed. Cure rates seem to be higher for patients with cagA+/vacA s1 H pylori strains, which is consistent with the higher cure rate observed among ulcer patients compared with functional dyspepsia patients. Therefore, treatment studies may require stratification for presence of ulcers as well as H pylori genotypes.
幽门螺杆菌的毒力因子与消化性溃疡疾病相关,也可能与治疗效果有关。
确定幽门螺杆菌的vacA和cagA状态、临床疾病及治疗结果之间的关系。
121例幽门螺杆菌感染且患有消化性溃疡疾病或功能性消化不良的患者,分别接受两组四联抗生素治疗,疗程分别为1天和2天。
从治疗前后采集的胃窦活检标本中提取DNA,通过聚合酶链反应和反向杂交确定vacA和cagA状态。
消化性溃疡疾病与vacA s1型及cagA阳性显著相关,但与vacA m型无关。消化性溃疡疾病患者或感染cagA+/vacA s1菌株的患者治疗效果显著更高。
证实了cagA和vacA状态与消化性溃疡疾病之间存在密切关联。cagA+/vacA s1幽门螺杆菌菌株感染的患者治愈率似乎更高,这与溃疡患者相比功能性消化不良患者观察到的更高治愈率一致。因此,治疗研究可能需要根据溃疡的存在情况以及幽门螺杆菌基因型进行分层。